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In recognition of the 20-year anniversary of the 
Methadone Treatment Protocol in 2018, the Irish 
College of General Practitioners (ICGP) has brought 
together a series of reflections of their Substance 
Misuse Programme.1 This comprises articles 
and extracts from Forum, the journal of ICGP, 
summaries of ICGP publications, pictures, and 
personal reflections from doctors and patients.
Context to the Methadone Treatment Protocol in 
Ireland
Fifty years ago, the first Working Party on Drug Abuse was 
established in Ireland, after which came a series of committees 
leading to the introduction of the Misuse of Drugs Act, 1972. 
By 1983, an escalation of problem opiate use was apparent, 
particularly in relation to injecting drug use and the risk of HIV, 
prompting a response from health professionals and authorities. In 
1989, Professor Gerard Bury wrote that:
General practice has much to offer in the care of drug 
misusers. The unique relationship between many GPs and 
their patients is an important resource in educating and 
motivating misusers to change their pattern of use. This is 
particularly important with respect to high-risk practices for 
the transmission of HIV. (p. 5)2 
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In brief
The Report of the rapid expert review of the 
National Drugs Strategy 2009−2016 noted that one 
of the key features of that strategy was the strong 
role of community organisations in both strategy 
development and delivery. This role is maintained 
in the current strategy, and community and 
voluntary services are partners with the statutory 
section in delivering the interventions that drive 
the strategy. 
The rapid expert review also observed that coordination 
between local, regional and national levels became less 
effective over time. While the review team frequently 
observed good practice at the local level, blurred 
communication impeded the task of making this good 
practice systemic and also made roles and responsibilities 
less clear. There are several practical reasons for supporting 
the role of community-based organisations (CBO), defined 
in the literature as not-for-profit civil society organisations 
with particular governance structures and whose strategic 
objectives are developed in consultation with community 
stakeholders. CBOs providing, or coordinating, services 
to socially excluded groups play an important role in the 
delivery of health programmes. United Nations/World 
Health Organization documents and strategies frequently 
emphasise the role of CBOs in health activities and the 
need to strengthen intersectoral collaboration and increase 
participation in decision-making around health strategies.  
The recent National Drugs Forum provided an opportunity 
for CBOs and other organisations to highlight the work that 
they are doing and to share knowledge with others. While 
these kinds of learning opportunities are important, ensuring 
that evidence is used effectively and that interventions are 
monitored will need a structured approach with a sound 
theoretical basis. Supporting the CBO’s use of evidence 
is an effective way to link research to action in health 
programmes. One approach to this work is to develop 
a strategy of community-based knowledge transfer and 
exchange (KTE). KTE is used as a broad umbrella term for 
activities which facilitate the use of research evidence 
in service planning and delivery. Research on this topic 
identifies four main barriers to the use of research in CBO 
work: several other factors are involved in decision-making; 
research evidence is not valued; a lack of available relevant 
evidence; and the difficulty in using research evidence. 
Approaches to overcoming these barriers include fostering a 
culture favourable to the use of evidence; providing evidence 
that is directly relevant to the work of these organisations; 
and providing support to them to evaluate the impact of 
strategies designed to link research to action. Reports 
on each of the workshops held during the National Drugs 
Forum are presented in this issue. These reports are a useful 
reminder of the quality and impact of the work that is being 
done and also of the particular challenges faced by non-
statutory organisations in delivering services.
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possibility of normalizing addiction treatment, … 
building in a variety of safeguards for doctors, their 
patients and the community at large in a clever 
piece of legislative action in an unusually complex 
policy arena. Credit for the Methadone Protocol, 
it seems to me, should be shared amongst several 
stakeholder groups: from the early-1990s onwards, 
Dublin GPs who had worked responsibly (and without 
much thanks) with drug users were joined by a new 
cohort of GPs who had experience of this kind in the 
UK; the voluntary harm reduction agencies (chiefly 
the Ana Liffey Project and Merchants Quay Ireland) 
played a helpful role; and, as already indicated, some 
Department of Health officials were crucial to this 
process. 
Dr Shane Butler, Emeritus Fellow, Trinity College 
Dublin (p. 30)
Proven successful model of managing chronic 
disease – where to from here?
The editors of the publication point to the key role that GPs 
will continue to have in identifying and caring for patients 
with addiction problems, highlighting the ongoing problems 
of alcohol, benzodiazepine and over-the-counter codeine 
misuse in addition to opiate problems. In primary care, there is 
the opportunity to normalise addiction treatment and reduce 
the stigma of opiate substitution treatment, particularly as a 
long-term treatment. Although much has been achieved over 
the past two decades, there remain significant challenges; for 
example, waiting times in parts of the country, lack of choice 
of opiate substitution medication for patients, and poor 
patient experiences in relation to service provision. The editors 
recommend the full implementation of the recommendations 
of the external review of the protocol, conducted by Professor 
Michael Farrell and Professor Joe Barry in 2010.4 
Suzi Lyons
1 Delargy I, Doran G and Patton P (eds) (2018) 20 years of the 
Methadone Treatment Protocol in Ireland. Dublin: Irish College of 
General Practitioners. https://www.drugsandalcohol.ie/29872/ 
2 Bury G (1989) Drug problems in Dublin. The Practitioner, 233: 
1486–89. https://www.drugsandalcohol.ie/6704/ 
3   National Co-ordinating Committee on Drug Abuse (1991) 
Government strategy to prevent drug misuse. Dublin: Department 
of Health. https://www.drugsandalcohol.ie/5108/ 
4 Farrell Ml and Barry J (2010) The introduction of the opioid 
treatment protocol. Dublin: Health Service Executive.  
https://www.drugsandalcohol.ie/14458/ 
By 1991, the role of general practitioners (GPs) in providing 
methadone treatment was cemented in the Government 
strategy to prevent drug misuse, which highlighted the role of 
GPs in the community for caring for problem drug users.3
ICGP substance misuse programme: the first 
two decades
When the Methadone Treatment Protocol was introduced 
in 1998, it brought about a change in practice; for example, 
methadone replaced Physeptone as the choice of opiate 
substitute. There was a significant amount of cooperation 
and work needed between all partners to get the programme 
started, which was initially limited to the Greater Dublin Area. 
Since then, the number of clients receiving methadone both in 
clinics and with GPs has expanded greatly.
Dr John Latham, writing for Forum in March 2018, said of the 
methadone protocol: 
Twenty years on, the Opioid Protocol remains a 
remarkable system of life-saving, health-enhancing, 
public health positive care in the community. The 
protocol has ensured that this care is now available 
to about 10,000 patients nationwide. Practice has 
changed with regard to frequency and observation of 
urine sampling and I hope in future there will be more 
emphasis on encouragement and safe care for those 
wishing to detox and become drug-free. (p. 15)
The ‘Education and innovations through the years’ section 
showcases the education and training developments over the 
past 20 years in the ICGP related to substance misuse.
‘Reflections on 20 years of the Methadone Treatment Protocol 
in Ireland’ is a collection from professionals and clients on 
the overall success of the programme, two of which are 
reproduced below:
It’s been extraordinarily helpful. I don’t want to be on 
it forever but certainly as I become more and more 
stable and I am able to benefit from the support 
structures I have as a result of that stability. 
Anonymous client (p. 28)
The implementation of the Methadone Treatment 
Protocol in 1998 represented the most radical 
abandonment of such negative ideas about the 
Twenty years of the Methadone 
Treatment Protocol continued
Professor Sir John 
Strang (left) and Dr 
Eamon Keenan at the 
Methadone Treatment 
Protocol event in the 
Royal Irish Academy
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9 WORKSHOP 1: Supporting prevention work in 
the community
Planet Youth 
Michéal Durcan, Western Region Drug and Alcohol Task Force 
(WRDATF)
Planet Youth is an evidence-based approach to preventing 
children and adolescents from initiating drug use. The model 
originated in Iceland and has been rolled out in communities 
in 18 countries to date. A dramatic decrease in substance use 
among Icelandic adolescents since 1997 has been attributed to 
this model. In the 1990s, a group of Icelandic social scientists, 
policymakers and practitioners began collaborating in an 
effort to address the increasing levels of drug and alcohol use 
among Icelandic young people. The prevention model that 
emerged involves the regular collection of data from young 
people through a school-based questionnaire on background 
factors, substance use, social circumstances, and potential 
risk and protective factors associated with substance use. The 
findings are used by local stakeholders to plan and deliver 
a set of prevention responses. There was a broad range of 
prevention interventions introduced in Iceland, which involved 
significant public expenditure, for example, structured high-
quality recreational activities for young people and support 
for families to spend more time together. The impact of the 
interventions is then measured through regular data collection, 
interventions amended in response to the findings, and any 
new issues identified. The outcomes found in Iceland have gone 
beyond drug and alcohol use and include: lower suicide rates; 
lower obesity rates; less alcohol use at university age; improved 
general mental health and wellbeing; improved youth facilities 
and services; less early school leaving; and, less crime and 
imprisonment.
POLICY AND LEGISLATION 
National Drugs Forum 
2018: reports on 
workshops
One of the aims of the first National Drugs Forum was to 
provide an opportunity for community-based services to 
inform colleagues about their work, to exchange knowledge 
around what works, and to identify information gaps. The 
workshops were a recognition the dynamism and commitment 
of these services. 
They were designed to enable shared learning and encourage 
discussion among practitioners, activists and administrators 
who face similar challenges. The forum appointed a rapporteur 
to each workshop and a brief report on each workshop was 
presented at the final plenary session. The rapporteurs’ final 
reports are presented below. 
Each report presents an overview of each presentation, 
including some key issues raised in the discussion after each 
presentation. 
More details on the content of the presentations are available 
through the slide packs available at:    
https://www.drugsandalcohol.ie/php/ndfabstracts.php
From L to R: Dr 
Brigitte Manteuffel of 
the Georgia Health 
Policy Center; Minister 
Catherine Byrne TD; Dr 
Darrin Morrisey, chief 
executive of the Health 
Research Board; and 
Dr Karen Minyard, 
director of the Georgia 
Health Policy Center, 
at the National Drugs 
Forum
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National Drugs Forum continued
In association with local partners, WRDATF has committed 
to supporting the introduction of Planet Youth in parts of 
the region: the task force has committed to taking the lead 
on managing the survey and its analysis. Because of the 
resources required, in collaboration with WRDATF, other 
agencies (e.g. Tusla and the Health Service Executive) will have 
to take responsibility for developing the interventions. Data 
have been collected using the standardised Planet Youth tool 
with students in transition year in secondary schools across 
Galway, Mayo and Roscommon. Data collection was successful 
with 4,600 forms returned from across 83 schools. These 
are currently being analysed by the team in Iceland and the 
findings of this baseline survey will be reported on at the end of 
February 2019. 
Key points made in the discussion:
• There is a need to ensure that interventions from the 
Planet Youth model are adapted so that they are culturally 
appropriate. For example, the curfews imposed in Iceland 
would not be appropriate in the Irish context.
• The funding structure in Iceland allows for taxes collected 
locally to be spent locally. An innovative and clever 
approach to resourcing the project in the western region 
will be required.
• There are good relationships with sporting clubs and 
facilities in the western region that could be supported to 
develop innovative interventions.
• Innovative approaches will be needed to engage with 
parents. Parents who attend regularly can help build 
capacity within the community.
• There needs to be a long-term commitment to this 
programme: change will take at least a couple of years to 
bring about.
• The programme would benefit from establishing a formal 
mechanism through which young people could contribute 
to the development of initiatives and the programme as a 
whole.
Drug-Related Intimidation Reporting Programme: 
interagency working and supporting families
Aoife Frances, National Family Support Network, and Brian Woods, 
Garda National Drugs and Organised Crime Bureau
The National Family Support Network (NFSN) is a self-help 
organisation supporting the development of family support 
groups and networks throughout Ireland. Through its work it 
raises awareness of the difficulties faced by families in coping 
with substance misuse, while recognising the important role 
that families play in supporting the recovery of the person 
using drugs. NFSN identified the need for a programme to 
support those experiencing drug-related intimidation and debt. 
Approximately one-third of the calls for support they were 
receiving related to these issues. 
Most calls come from mothers of people who use drugs and 
who were in debt. In response to this, NFSN worked with the 
Garda National Drugs Unit (now part of the Garda National 
Drugs and Organised Crime Bureau) to establish the Drug-
Related Intimidation Reporting Programme (DRIRP) in 2013. 
The purpose of the programme is to respond to the needs 
of drug users and family members who are experiencing 
drug-related intimidation. It is a challenging programme and 
the speakers noted that drug-related intimidation is not 
an issue that receives much discussion in other European 
countries. Therefore, there is a lack of knowledge and evidence 
about how best to set up and run such a programme. Both 
organisations are undertaking a review of the programme.
Key points presented in the workshop:
• Good positive collaboration between the delivery partners 
is essential for the success of the programme.
• Family members are hesitant about approaching the Gardaí 
in the traditional way for a number of reasons, including 
fear of reprisal from dealers and that their family member 
would be arrested given that possession is criminalised. 
Professor Harry Sumnall 
of Liverpool John 
Moores University 
speaking at the National 
Drugs Forum
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• Gardaí are trained through the programme to support the 
families. An important feature is that people can meet with 
the nominated Garda Inspector but there is no obligation 
on the family to make a formal complaint. They can just get 
support and advice.
• Staff and client safety are of major concern. 
• The consistency in language that has come from the 
programme to name ‘intimidation’ is helpful – this has been 
seen as positive for families and communities.
• Dealing with drug-related intimidation is a priority in the 
current policing plan. To back this up, there are new strands 
of training on drug-related issues under development for 
Gardaí.
• The NFSN is planning to deliver a train-the-trainer 
programme for organisations around the country so 
that they can work with their local Gardaí on the topic. 
Additional resources are needed. 
Key points made in the discussion:
• While there is a need nationally for services that support 
those experiencing intimidation, projects do not want to be 
identified as an ‘intimidation project’ as such. It presents 
too many risks for staff and clients/participants.
• Ongoing cuts in funding for community projects put 
communities at increased risk.
• Initiatives such as DRIRP need careful evaluation; there is a 
need to look at how they coordinate with communities in 
particular.
• Resources need to be made available to provide the 
services and make the necessary changes in response to 
the findings of any evaluation/research.
• The requirement of any community programme, such as 
the Social Inclusion and Community Activation Programme 
(SICAP), to ask for participants’ names and supporting 
information was described as a ‘disaster’. It prevents people 
who are experiencing intimidation from accessing services.
The Let’s Learn About Drugs and Alcohol Together 
(LLADAT) programme
Sancha Power, Health Service Executive
Let’s Learn About Drugs and Alcohol Together (LLADAT) is an 
alcohol awareness and drug education programme aimed at 
second-year senior cycle students and their parents in the 
Mid-West. It is designed to support the existing work being 
carried out in schools through Social, Personal and Health 
Education (SPHE) and the new Wellbeing programme. It sets 
out to engage parents in shared dialogue around substance use 
through two workshop sessions that are held during out-of-
school hours. The first workshop is just for parents; the second 
for parents and pupils. The presenter noted that it is ‘hard 
to evidence education and prevention initiatives’; therefore, 
to illustrate the success of the programme she reported on, 
for example, positive relationships with participants and the 
ongoing interest of schools in the programme. Among the 
strengths of the programme identified were that it takes a 
multimodal approach, it encompasses the family, and supports 
what is already being delivered in schools.
Key points made in the discussion:
• The programme is not available to be delivered elsewhere 
at the moment.
• There were some concerns about the programme covering 
solvent use – that this may encourage its use in a context 
where they were no longer widely used. However, the 
presenter noted that their use was evident in the area of 
delivery.
Design and implementation of a pilot programme to 
reduce student drinking: Responding to Excessive Alcohol 
Consumption in Third-level (REACT)
Susan Calnan, University College Cork
High levels of alcohol use have been found among third-level 
students in Ireland. In 2014, the Health Service Executive (HSE) 
commissioned a research team to develop a public health 
intervention to address alcohol use among third-level students. 
Responding to Excessive Alcohol Consumption in Third-
level (REACT) was developed in collaboration with the Health 
Matters team at University College Cork, the Irish Student 
Health Association, and the Union of Students in Ireland (USI). 
Its development followed a three-step process: systematic 
review, knowledge exchange forum, and expert consultation. 
The programme is an environmental rather than an educational 
initiative; as such it takes a settings approach rather than 
focusing on the individual. Therefore, it is focused on bringing 
about change in the culture, processes and policies of the 
university in relation to alcohol use. For example, the presenter 
mentioned interventions such as offering alcohol-free student 
accommodation and social spaces. REACT is currently being 
implemented in 15 higher education institutions across Ireland. 
While the programme’s evaluation has not yet been completed, 
the presentation covered a range of preliminary findings from 
the process element of the evaluation and the work with 
students. 
Key points presented in the workshop:
• The majority of students who were engaging in hazardous 
drinking defined their own drinking as low risk – indicating 
low levels of awareness of own drinking among students. 
• In terms of concerns about their own drinking, ‘spending 
too much money on alcohol’ emerged as the biggest 
concern for students and ‘negative impact on physical 
health’ as the second biggest.
• A ‘considerable proportion’ of the students saw the control 
of alcohol consumption as their personal responsibility 
rather than that of the third-level institution they are 
attending. 
Key points made in the discussion:
• The need to have someone championing a programme such 
as REACT was highlighted; programmes need someone to 
take ownership for it to move forward.
• A settings approach to prevention such as that 
demonstrated by REACT was welcomed. It was suggested 
elsewhere that communities have a key role in delivering on 
prevention in their areas.
• It was suggested that it was not a matter of personal 
responsibility versus institutional responsibility when 
addressing hazardous drinking, rather it should be a 
combination of both. 
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WORKSHOP 2: Dual diagnosis: using 
partnership and peer support as resources in 
treatment
Dual Diagnosis: a community-led response 
Jennifer Clancy, Clondalkin Drug and Alcohol Task Force
The Drug and Alcohol Task Force Treatment and Rehabilitation 
subgroup had become aware of a higher number of more 
complex dual diagnosis cases, with little or no interagency 
casework. Initial meetings with the Community Mental Health 
Team took place in August 2014.
A social worker and clinical nurse manager joined the 
subgroup, and as part of the implementation of the National 
Drug Rehabilitation Framework, training on substance misuse 
issues and responses was delivered to mental health staff, and 
training on mental health issues and responses was delivered 
to substance misuse staff. This led to the establishment of an 
interagency Dual Diagnosis working group.
The working group gathered baseline data; identified barriers 
to developing care pathways; training needs; gaps in services; 
and formalised relationships between services. Documents to 
formalise shared care were developed and a case management 
approach agreed.
The outcomes of this approach were that there was a reduction 
in the duplication of services; integrated care pathways 
were developed; better understanding of different services’ 
roles; reduction in hospital stays; utilisation of standardised 
assessment tools; and the provision of Wellness Recovery 
Action Plan (WRAP) as part of general substance misuse service 
provision.
The establishment of a ‘seeking safety’ group in the 
National Drug Treatment Centre for supporting patients’ 
substance dependence and a history of trauma 
Siobhan Rooney and Ruth Anne Buckley, Health Service 
Executive
‘Seeking safety’ is a manualised, evidenced-based treatment for 
post-traumatic stress disorder/trauma and substance misuse, 
utilising cognitive behavioural therapy and psychoeducational 
approaches that are problem–solution oriented and can be 
applied in groups or in one-to-one sessions. The process 
commenced with staff training in the approach, with an 
advertisement for the planned group placed on the notice 
board in the National Drug Treatment Centre.
Sessions commenced by checking in with each participant, 
and continued with a quotation and handout from the manual. 
The objective is to engage with the client emotionally, provide 
a point of inspiration, and to relate the handout subject matter 
to the clients’ lives, with rehearsals of coping skills, role play, 
and discussions. Participants’ feedback was positive, with 
improvements in self-esteem, confidence, assertiveness, and 
with the course described by participants as practical and 
straightforward.
Elements considered important were peer support, the social 
aspect, lack of exclusion criteria, the ability to miss sessions and 
rejoin without requiring a catch-up, and peer learning.
Miriam Coffey of the 
North Inner City Drugs 
and Alcohol Task Force, 
who attended the 
National Drugs Forum in 
November 2018
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Addressing dual diagnosis within a residential treatment 
programme serving women with complex needs 
Anita Harris, Coolmine Therapeutic Community
The women’s residential service in Coolmine had identified 
a need for dual diagnosis supports, given that dual diagnosis 
was associated with higher dropout rates, lower psychological 
health, and high rates of prescribed medication to deal with the 
management of emotions.
The intervention was a mental healthcare plan, devised and 
coordinated by a visiting consultant psychiatrist, and delivered 
by both substance misuse and mental health staff, alongside the 
existing addiction treatment of the therapeutic community. The 
approach involved was psychoeducational, with a resistance to 
prescribing psychotropic medication for the first six weeks.
Features included reduced barriers to appropriate care, faster 
access to mental health services, an interagency approach, 
and integrated care planning. Outcomes included reduced 
medication, improved retention rates, improved family 
dynamics, reduced hospital emergency attendances, and 
improved mental health. 
Dual diagnosis: emotional regulation skills training in 
Keltoi
Peter Sherry and Ruth Anne Buckley, Health Service 
Executive
The development of an emotional regulation skills approach 
to substance misuse is based on the viewpoint that substance 
misuse is viewed as self-soothing behaviour. This is further 
complicated by the relationship between trauma and substance 
misuse. Various examples were presented from the literature to 
evidence this.
Emotional regulation incorporates individuals’ attempts to 
manage emotionally charged states, including anxiety, low 
mood, depression, stress and post-traumatic stress disorder. 
Keltoi staff observed hyper (hypervigilance, impulsivity and 
anger) and hypo (depression and disassociation) arousal states 
in clients, and conducted qualitative research in relation to the 
use of emotional regulation.
The emotional regulation skills training included use of the 
‘Window of Tolerance’ approach, mindfulness, cognitive 
behavioural therapy, and coping strategies. The evaluation 
indicated that participants developed an ability to identify and 
discuss their emotions, increased their self-esteem, self-
regulation, normalised their emotions, and increased their 
quality of life.
Key aspects were considered to include the ability to deliver 
the intervention in groups or as one-to-one; the ability to 
deliver the intervention to clients at various stages of their 
recovery; peer support; free staff training; dual use as a staff 
self-care tool.
Commonalities:
• Data: The four interventions/initiatives were able to identify 
the negative impact of not responding effectively to dual 
diagnosis, which bolstered their arguments for commencing 
their initiatives.
• Vision: Each had a model or intervention approach that 
they were able to describe clearly to their potential 
partners.
• First steps: Each were clear on what they were able to start 
with, were able to then learn from their experiences, and 
develop further positive working relationships with partners 
from those initial experiences.
Minister of State with 
responsibility for Health 
Promotion and the 
National Drugs Strategy, 
Catherine Byrne TD, 
giving the closing 
address at the National 
Drugs Forum
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WORKSHOP 3: The role of social reintegration 
in recovery
Social enterprise and co-production: a synergy-
promoting social reintegration
Paul Delaney, The Cornmarket Project, Wexford
The Cornmarket Project is an interagency community-based 
treatment and rehabilitation project under the auspices of 
Wexford Local Development. The project works with clients in 
recovery from substance addiction to promote a stable and 
productive lifestyle. The social enterprise and co-production 
initiative is a major plank of the portfolio of services provided 
by the Cornmarket Project. The social enterprise and co-
production initiative works with clients in recovery from 
substance addiction to improve their chances of moving 
to employment. The initiative grew from the Community 
Employment Drugs Rehabilitation scheme, which was a national 
initiative to promote vocational training and employment for 
clients in recovery. The social enterprise initiative designs 
t-shirts and bags and a wide range of paraphernalia that are 
used at conferences and other social events. The initiative 
has been recognised as an example of good practice and 
was awarded a place on the Social Innovation Fund’s social 
enterprise development accelerator programme 2018. An 
innovative feature of the social enterprise initiative is that 
participants receive a job reference to enable them to improve 
their chances of securing other employment opportunities. 
Clients working with the social enterprise initiative can also avail 
of working with the Change Outcome and Impact Measurement 
(COAIM) system, which forms a major part of the work in the 
Cornmarket Project overall. The COAIM system is focused on 
client assessment and progression and works with clients to 
improve their quality of life in 10 domains, including offending 
behaviour; accommodation; pro-social activities; anger and 
emotion management; attitudes and cognitive style; drug and 
alcohol misuse; lifestyle and associates; relationships and family 
issues; training and employability; and financial issues and debt. 
Data presented at the workshop suggest that clients achieved 
positive change in nine of the 10 domains; positive changes to 
accommodation status were less pronounced for clients, which 
are likely to be influenced by the shortage in accommodation 
options on a national basis. 
Key points presented in the workshop: 
• Co-production is not just a word, not just a concept, it is a 
meeting of minds coming together to find a shared solution. 
In practice, it involves people who use services being 
consulted, included, and working together from the start to 
the end of any project that affects them.
• Projects are strengthened when the focus is on measuring 
outcomes for clients rather than outputs for services.
• Projects need to recognise and understand the lived 
experience of people in recovery and offer them a holistic 
and integrated suite of services to meet their needs as they 
present.
• The quality of life indicators included in the COAIM system 
could be used by other services to assess progression and 
positive change in outcomes for clients.
Parents Under Pressure programme working with high-
risk families in recovery from substance addiction 
Emma Timmins, Parents Under Pressure programme 
The Parents Under Pressure (PUP) programme is primarily 
delivered in the residential setting of Ashleigh House, which is 
run by the Coolmine Therapeutic Community as part of the 
suite of services provided to clients in recovery from substance 
addiction. Ashleigh House is a residential therapeutic community 
for women, expectant women, and mothers with young children, 
and is designed to help women in recovery develop the skills 
they need to live a drug-free independent life. Ashleigh House is 
the only mother-and-child residential treatment programme in 
Ireland. The PUP programme was designed in Australia to cater 
for the needs of high-risk families, including families with parents 
in recovery for substance misuse. The programme recognises 
that parents who are receiving treatment for substance use quite 
often experience difficulties coping with other areas of life, such 
as family functioning, child behaviour problems, and mental 
health difficulties. The programme includes 12 core modules that 
are manual based and combine psychological principles with a 
case management model; it is delivered over a 20-week period. 
The programme is an assets-based intervention and promotes 
the development of empowerment and resilience in the target 
group. 
The workshop heard that the PUP programme was introduced to 
the women in recovery in Ashleigh house when staff identified a 
gap in service provision. Staff noticed that although the women 
were making progress in their recovery, for some of them it was 
difficult to develop an emotional attachment to their children. 
Their difficulties in forming these emotional attachments mainly 
stemmed from their feelings of guilt around letting down their 
children when they were in active addiction. These feelings of 
guilt were often exacerbated by their feelings of anxiety and 
depression, which staff believed, if left untreated, could undo 
a lot of the progress they were making on other matters. The 
main results from a recent evaluation of the PUP programme in 
Ashleigh House were cited in the workshop, and reported that 
women experienced reductions in depression, anxiety and stress 
when measured as part of the before-and-after assessments 
when the programme was introduced. 
Key points presented in the workshop:
• The PUP programme provides an opportunity for the 
women to engage in incremental learning, which means 
they have the chance to move at their own pace.
• A key mechanism of the programme is when the women 
accept that they do not need to be a perfect parent; a good 
enough parent will suffice, and being recognised as a parent 
is invaluable to the women.
• Women engaged in the programme build their own sense 
of belief through their efforts to become better parents, 
and the sharing of this belief with other women spreads the 
collective impact for many.
• The PUP programme has also been delivered through 
the day service recovery programme in Coolmine, and 
retention in the day service delivery is sometimes higher 
than that achieved in the residential setting.
• In some cases, the fathers of the children are also engaging 
with the PUP programme.
• The PUP programme provides the women with an 
opportunity to identify and develop their strengths as 
parents – vital to sustaining their progress and recovery. 
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Recovery coaching as a mechanism to build recovery 
capital
Paul Duff, Recovery Academy Ireland
Recovery Academy Ireland primarily comprises people 
in recovery from substance addiction and includes their 
supporters, advocates, researchers, and professionals who 
want to promote and champion the concept of recovery. 
The key objective of the academy is to create a community 
for those in recovery and give them, their families, and allies 
a voice and a vision of hope for the future. The Recovery 
Academy is instrumental in developing and supporting 
‘recovery coaches’ to mentor and give practical assistance to 
people in early recovery. A recovery coach is someone who has 
established and sustained their own recovery, has completed 
a training course in recovery coaching, and is committed to 
promoting recovery in the community and making recovery an 
attractive option. 
The core training course for recovery coaches is run over 
five days and involves talks and group work around the 
following topics: overview of recovery coaching; recovery 
pathways; ethics and professional practices; exploring the 
helping relationship; your own boundaries; disclosure and risk; 
communication and coaching skills; understanding and applying 
models of wellbeing and motivation; relapse; recovery check-
ins; and next steps. The training is accredited by OCN Learner 
Recovery Coaching Education. This is equivalent to QQI/FETAC 
Level 3 and is recognised in the United Kingdom.
Plans to expand the number of recovery coaches in Ireland 
were outlined to the workshop. It was proposed that a total of 
32 coaches will be trained in two rounds of training from 2019; 
this will include 17 coaches from the Greater Dublin Area and 
15 nationally, from outside Dublin. In addition to the formal 
training, they will do 12 hours a week voluntary work over a 
25-week placement in relevant services with additional training. 
They will be supervised by a mentor with oversight from the 
coordinator over the 25 weeks of placement.
Key points presented in the workshop:
• Recovery coaches help to build recovery capital in 
communities.
• Recovery coaches draw on their life experiences, which is 
an invaluable resource, to improve outcomes for others and 
their communities.
• The work of the Recovery Academy and in particular the 
development of recovery coaches has helped people to 
celebrate their recovery.
• There remains much work to be done to promote recovery 
from substance addiction, as people in recovery often face 
a double stigma; they are stigmatised for their addiction 
and for being in recovery.
• People in recovery often contend with multiple recoveries 
and require additional support to what has traditionally 
been delivered via the 9–5 service delivery model; self-
help groups and communities of recovery can provide this 
additional support. 
Peer Leadership Development and Integration programme
Nicola Perry, Community Response
The Peer Leadership Development and Integration programme 
is delivered over 30 hours in total and spans six weeks’ delivery. 
The programme includes 10 modules with the aim of developing 
a range of competencies required to build capacity in peer 
leadership and underpin facilitation and engagement in a group 
environment. The overall aim of the programme is to build 
individual resilience, capacity, and social capital to sustain 
recovery and community inclusion. 
The workshop learned about the results of an evaluation of 
the programme that included 20 participants completing two 
programmes of training. Participants were assessed before 
and after they engaged with the training. It was claimed that 
participants reported a 25% improvement in motivation, 
a 40% increase in their capacity to provide peer support, 
and 92% indicated an improvement in their own health and 
wellbeing. In addition, participants reported an increase in 
levels of knowledge, skills, and competencies in relation to the 
programme modules. 
Overall, improvements were noted in motivation, ambition, 
personal development, peer support, and personal stability; it 
was claimed that the outcome areas assessed were deemed 
material to building social capital to help sustain rehabilitation 
and build capacity for peer leadership. It is planned to roll out 
four more programmes to create a wider base of participants 
in 2018/19. 
Key points presented in the workshop:
• The programme benefitted from a mid-programme review 
which integrated feedback from participants and allowed 
for real-time changes to be made to the modules and the 
delivery of the programme to incorporate learning that 
participants identified as part of their training needs.
• The programme benefitted greatly from the input by 
participants and intends to include former participants in 
the next roll-outs, for development and inclusion.
• The programme coordinators plan to have inputs about 
post-course training options built into the core programme 
for greater clarity.
• Key to the success of the programme is creating a safe 
space where participants can feel free to experiment with 
change. 
WORKSHOP 4: Harm reduction services: 
engaging with people who use drugs
Assertive Case Management: a collaborative approach to 
target supports at those most at risk
Dawn Russell, Ana Liffey Drug Project
This presentation described two of Ana Liffey’s low threshold 
projects ongoing in Dublin city which provide case management 
based on National Drugs Rehabilitation Framework (NDRF) 
tools. These projects are delivered by a multidisciplinary team 
targeting clients with complex needs or those not currently 
engaging with existing services through outreach, in-reach, or 
home visits where required. The projects are slightly varied as 
they catered for different groups in two different parts of the 
city. The projects had input from a wide range of stakeholders, 
including An Garda Síochána. 
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The outcomes were measured using care plan goals, the Pulse 
system, and self-assessment using standardised questionnaires. 
Given the client group, there were indications of success in 
both groups, such as improved engagement with health and 
addiction services and reduced antisocial behaviour. 
Summary of presentation, highlighting what had worked 
well in the two different projects: 
• Multiagency oversight group
• Clear tasks and targets
• Regular, action-focused case meetings
• Case meetings with An Garda Síochána (where appropriate).
And what did not work so well:
• Clients unable to meet the current entry criteria for 
detoxification services
• Application of Outcomes Star (an assessment tool for 
measuring change)
• Lack of shared care plans under NDRF
• Lack of clarity about continuum of care and access criteria.
A collaborative response to chemsex in Ireland 
Kiran Santlal and Adam Shanley, Gay Men’s Health Service
The presenters first gave a detailed overview of chemsex, that 
is, the use of drugs (frequently GHB) to facilitate or enhance 
sexual experience and the often complex issues related to the 
practice. There was a summary of a recent study which found 
in the target group that 27% of those who responded had 
engaged in chemsex in the previous 12 months. For example, 
one-quarter reported that chemsex had a negative impact on 
their lives and one-third felt that they would like help or advice 
about it.
The collaborative approach to addressing this issue was 
described by the presenters. It involved the Health Service 
Executive, the Gay Men’s Health Service, HIV Ireland, Gay 
Switchboard Ireland, BeLonG To, Healthy Ireland and Drugs.ie. 
The goal was to address not just drug use but also sexual and 
mental health in any intervention. The primary intervention 
was the provision of harm reduction advice and information in 
clubs, universities, etc. 
The secondary intervention was to assess the harmful use of 
GHB in services where LGBT people access health or addiction 
services, for example, Gay Men’s Health Service or Ana Liffey 
Drugs Project. The tertiary services manage the harmful effects 
of using GHB through treatment, for example, detoxification 
in the National Drug Treatment Centre (NDTC). There have 
been 98 referrals for GHB detoxification since 2014, where the 
majority received treatment as outpatients. 
Key points presented in the workshop:
• The Chemsex Working Group needed to involve many 
different agencies in order to address this complex issue 
and is a good example of multiagency cooperation.
• There are significant health and psychological risks related 
to chemsex, which require specific interventions, some of 
which need to be long term to prevent relapse. 
• GHB detoxification can be successfully managed in the 
NDTC clinic as an outpatient. 
• To address the problems associated with chemsex, agencies 
must continue to look for innovative ways to target these 
high-risk populations.
‘I’m not a lone soldier’: a multidisciplinary response to 
the management and treatment of benzodiazepine use 
within the general practitioner setting
David Gibney and Brian Foley, Ballymun GP Community 
Partnership Addiction Project
This multidisciplinary partnership for problem benzodiazepine 
use is located in the Ballymun Family Practice, delivered by 
staff from Ballymun Youth Action Project and funded by the 
Ballymun Local Drug and Alcohol Task Force. It has been 
running since 2006, in response to a study in the area which 
highlighted the problems with benzodiazepines.
The aim of the partnership is to provide a service for people 
who want to address their benzodiazepine use, including 
accessing detoxification or further treatment. Every week, nine 
dedicated hours of counselling are provided either at the GP 
practice or at another centre by a trained addiction counsellor. 
The project allows better, more flexible (and more discreet) 
accessibility to treatment, earlier intervention, and integration 
of medical and psychosocial services. It improves links with 
other services and does reach other problem drugs, such as 
alcohol and methadone. 
The majority of clients are men and most receive counselling. 
The most common presenting drug was Valium or a Z-drug, 
followed by alcohol and cocaine. Many have a dual diagnosis. 
There were positive outcomes for many of the clients.
The presentation summarised some of the important lessons 
learned in relation to improving GP knowledge of current street 
tablet use, addiction counselling, importance of providing a 
non-stigmatising location, and multidisciplinary cooperation.
SAFE campaign
Emma Fox, Clondalkin Drug and Alcohol Task Force 
The SAFE campaign developed initially because of concerns 
raised by An Garda Síochána and Irish Rail about a rise in public 
drug use and antisocial behaviour around the train station in 
Clondalkin, Dublin. This led to the creation of an interagency 
group to look at solutions to the issue, comprising initially 
Clondalkin Drug and Alcohol Task Force (CDATF), An Garda 
Síochána, Irish Rail, various local addiction services, and then 
joined by the South Western Regional Drug and Alcohol Task 
Force (SWRDATF), the Health Service Executive and other 
addiction services to provide support along the Kildare–Dublin 
railway line. 
At the initial meetings, the partners raised their individual 
concerns and together the joint initiative was formulated. 
SWRDATF, Ana Liffey Drug Project, South Dublin County Council 
and the HSE Addiction Services Outreach Team were brought 
on board to provide the interventions. The aim of the initiative 
was to provide information to the target group about services 
available locally. Additionally, the initiative wanted to reduce 
drug litter, levels of public drug use, and antisocial behaviour in 
the train stations. A steering group was set up to progress the 
initiatives. The presenter stressed that all this was done with no 
extra resources but with ‘goodwill and genuine buy-in’.
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discussion:
• A gap or need was identified by different agencies which 
brought them together to work collaboratively.
• Each partner was able to bring their own experience and 
perspective to the process and pool resources to address 
the issue. This process needed transparency.
• Goodwill and buy-in, along with a common goal, enabled 
the process to succeed in the four examples. 
• Any interventions or approaches need to be client-centred, 
because what they identify as important may not be what 
drug services feel is most important. This is vital as the 
target group for these interventions cannot or will not 
access services through the traditional pathways either 
because of complex needs or fear of stigma, for example.
• The interventions therefore also need to be appropriate. 
This often calls for novel or innovative approaches to meet 
the needs of this client group. Such new interventions 
can sometimes be met with resistance; therefore, time is 
needed to build trust and relationships between services 
and clients.
• The success of the projects not only depended on the 
good interagency cooperation but very much on the 
skill, dedication, and expertise of the staff delivering the 
interventions.
The reports on the workshops were compiled by Lucy Dillon, 
Chris Purnell, Martin Keane, and Suzi Lyons. The workshops 
were chaired by Tara Deasy, William Flannery, Joe Kirby, and 
Eamon Keenan.
The National Drugs Forum would like to thank the chairs and 
rapporteurs of all these sessions for their generosity and 
professionalism and for their excellent work prior to, during, and 
following the forum.
In March 2018, the SAFE programme was rolled out on a pilot 
basis, where an outreach team would try to engage with those 
in the identified location once a week. It was officially launched 
in October 2018.
Part of the remit of the steering group was to collect 
information on the situation. Clondalkin’s location on the edge 
of Dublin made it easily accessible to people from Kildare, 
Laois, Westmeath and Tipperary. People reported coming to 
Clondalkin to buy drugs or to access services anonymously. The 
age ranged from 21 to 58 years and 60% were women. Noted 
among the group were limited information about safe injecting 
and limited access to services in their own area. The problem 
of crack cocaine was also highlighted.
Positive outcomes and successful factors:
• Some very positive outcomes included: 257 client 
engagements; 240 clients availed of clean safe equipment; 
reduction of drug litter and antisocial behaviour.
• The successful factors identified in the process were: 
       –  There was a collaborative approach from all partners,  
building professional relationships, with commitment  
to the process.
       –  There were clear roles and responsibilities for the   
steering group, providing guidance and delivering 
outputs. 
       –  There was an experienced outreach team able to make 
contact and build trust and relationships with the 
clients.
       –  There was regular communication between the 
outreach team and the steering group, with a lead 
driver for the project locally. 
National Drugs Forum continued
Dr Karen Minyard 
speaking at the National 
Drugs Forum
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Not criminals – 
decriminalisation in 
Ireland
Decriminalisation of limited amounts of drugs for personal use 
in Ireland would involve changing the current law that defines 
possession of drugs for personal use as a criminal offence.1 
This does not mean that possession for personal use would 
be legal, as an administrative offence and civil sanctions may 
still be applied. Furthermore, it would not affect the law that 
makes the possession of drugs for sale or supply a criminal 
offence. Decriminalisation is currently being considered by a 
working group jointly led by the Department of Health and the 
Department of Justice and Equality. The group was established 
in December 2017 to deliver on a commitment in the national 
drugs strategy to ‘consider the approaches taken in other 
jurisdictions to the possession of small quantities of drugs for 
personal use with a view to making recommendations on policy 
options to the relevant Minister within 12 months’ (p. 58).2 The 
group has undertaken research and consultation to identify 
alternatives to the current system and to ensure that any 
alternatives would be appropriate in the Irish context.
Civil society
The debate has attracted the attention of many of those 
working with people who use drugs, including the Ana Liffey 
Drug Project (ALDP) and the CityWide Drugs Crisis Campaign.3 
Since 2015, the International Drug Policy Unit at the London 
School of Economics and Political Science (LSE) has been 
working with ALDP with the aim of advocating for and 
supporting progressive drug policies in Ireland. As part of this 
work, they have informed and facilitated discussions in Ireland 
about the decriminalisation of small amounts of drugs for 
personal use. There have been two recent outputs from this 
collaboration: a series of ‘town hall’ type meetings and the 
publication of the report Not criminals, which explores various 
aspects of decriminalisation.4
Town hall meetings
The first of a national series of town hall style meetings to 
increase awareness and understanding of what progressive drug 
policy is, with a particular focus on decriminalisation, was held 
in Wood Quay Venue, Dublin on 12 June 2018. Panel members 
were Dr John Collins, director of the International Drug Policy 
Unit at LSE; Tony Duffin and Marcus Keane of ALDP; and Anna 
Quigley of CityWide Drugs Crisis Campaign. Contributions 
were also made by GAA sportsman Philly McMahon and writer 
and actor Emmet Kirwan. Panelists highlighted the change in 
the Government drugs strategy towards a more health-led 
approach, away from dealing with drug use and addiction 
as a criminal issue. The current legal situation in Ireland was 
described, alongside what decriminalisation might look like 
here, all of which were placed in the context of international 
evidence on the topic. 
Not criminals
In October 2018, Not criminals was launched.4 Speakers at the 
launch were Marcus Keane, Dr John Collins, Prof Catherine 
Comiskey of Trinity College Dublin, and Dr Nuno Capaz, vice-
president of Portugal’s Drug Addiction Dissuasion Commission. 
The report provides ‘an evidence source on the adoption of 
a health led approach to the possession of small amounts of 
drugs for personal use’ (p. 3).4 Ireland is described as being 
at a pivotal point in drug policy. The national drugs strategy 
offers an opportunity for policymakers to act on its health-led 
focus by legislating for decriminalisation. The report maps the 
evolution of international and national drug policy; describes 
in detail the law in Ireland as it relates to simple possession; 
presents evidence of the impact the current system has for 
users; and provides an overview of decriminalisation in Portugal 
and the Czech Republic.
Health-led policy 
There has been a shift in the international policy debate away 
from considering criminal law as the best way to address 
personal drug use. The harms of criminalising the use of drugs 
are well documented and alternative approaches are being 
considered internationally. While Ireland’s current national 
drugs strategy reflects a health-led position in line with this 
shift, through an analysis of Oireachtas debates the authors 
found that a focus on users’ health is not new in Irish drug 
policy. While possession for personal use has been criminalised 
in Ireland since the introduction of the Misuse of Drugs Act in 
1977,5 punishment was not a primary focus of policymakers at 
the time. The debates that preceded the introduction of the 
1977 Act illustrate that they were concerned about the health of 
people using drugs and considered them in need of care rather 
than punishment. 
Irish law
Despite this, section 3 of the 1977 Act allows for the punishment 
of those found in possession of controlled substances for 
personal use. The penalties applied vary and depend on a 
number of factors, most importantly whether the substance 
is cannabis or another controlled substance, and whether this 
is the person’s first offence. While penalties can include up to 
seven years in prison, the report concludes that in practice 
the system takes a more humane approach. It notes that the 
Director of Public Prosecution elects for summary disposal 
in all cases of simple possession. Despite this more humane 
approach, a significant number of people are affected by this 
law each year: ‘In 2017, there were 12,201 recorded incidents 
of possession of drugs for personal use, representing over 70% 
of all drug related offences. The District Court received 20,746 
drugs offences involving 13,033 defendants in 2016’ (p. 35).4
Impact of criminalisation
The negative impact of criminalising people for their drug 
use is illustrated, for example, by stigmatising people and 
limiting their future employment opportunities. Indeed, 
criminalising possession as a policy response is not considered 
effective – it is reported that there is no clear link between 
the harshness of a country’s policy on possession of drug use 
and levels of drug use. In turn the available evidence does not 
support the argument that decriminalisation has an effect 
on broader trends such as prevalence. Indeed, where it has 
been introduced, as part of a comprehensive policy approach, 
decriminalisation has been found to be associated with a range 
of positive health and social outcomes.
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At both the town hall meeting in Dublin and the launch of the 
report, audiences overwhelmingly welcomed the proposal to 
decriminalise. However, there were concerns expressed by 
some attending the events that decriminalisation could be 
perceived as sending a message to young people that drug 
use is no longer problematic and that the prevalence of use 
might increase. Feedback at both sessions would also suggest 
that there is a lack of understanding among some of those 
working in the area and the public more generally about what 
decriminalisation is and how it differs from legalisation and 
regulation. The working group was due to report to the Minister 
of State with responsibility for Health Promotion and the 
National Drugs Strategy by the end of 2018.
Lucy Dillon
1 The term ‘decriminalisation’ is used for the remainder of this 
article to refer to the decriminalisation of possession of drugs for 
personal use.
2 Department of Health (2017) Reducing harm, supporting recovery: 
a health-led response to drug and alcohol use in Ireland 
2017–2025. Dublin: Department of Health.   
 https://www.drugsandalcohol.ie/27603/
3 The CityWide Drugs Crisis Campaign website on decriminalisation 
was covered in issue 63 of Drugnet Ireland. It can be accessed on: 
https://www.drugsandalcohol.ie/28230/ and   
https://www.citywide.ie/decriminalisation/
4 Keane M, Csete J, Collins J and Duffin T (2018) Not criminals: 
underpinning a health-led approach to drug use. Dublin: Ana 
Liffey Drug Project and London School of Economics and Political 
Science. https://www.drugsandalcohol.ie/29791/
5 Misuse of Drugs Act 1977. Available online at:   
http://www.irishstatutebook.ie/eli/1977/act/12/enacted/en/html
Decriminalisation continued
Report recommendations
Based on their examination of the international evidence and 
the legal and policy context in Ireland, the authors make three 
recommendations (p. 5):4
1     That Ireland decriminalise possession of small amounts 
of drugs for personal use. Continued criminalisation 
of people who use drugs is unsupportable by the best 
available evidence as a policy choice, and is in stark 
contradiction to a health-led policy for drug use.
2    That, in designing such a policy, the focus is on pragmatic 
interventions which focus on health, and include the 
following:
(a) Threshold limits which are reasonable, reflect the lived 
experience of people who use drugs and which serve as 
broad guidelines, not as inflexible standards. To protect 
against people attempting to thwart the system, intent 
should also be a key consideration for decision makers 
where people are in possession of small amounts
(b) Sanctions which are not punitive, but solely health 
based, supportive, voluntary and with as many 
opportunities afforded to the individual as needed. The 
sanctions chosen should recognise that not all drug 
use is problematic, and where possible, utilise existing 
structures and services, with defined pathways and 
interventions set in advance
(c) Decisions that are taken as close to the first point of 
contact as possible
(d) Training for health workers, educators, law enforcement 
and judiciary on the aims and implementation of the 
new system
3   That any policy that is introduced be independently 
evaluated in terms of implementation and impact, and that 
adequate resources be made available for this purpose.
Minority communities 
and the press
On 24 October 2018, the Press Council of Ireland and the 
Office of the Press Ombudsman held a seminar on ‘Minority 
Communities and the Press’. The aim of the event was ‘to hear 
about the critical role the print media plays in advancing the 
participation and representation of minority communities 
in society’.1 Presentations were made by those working in 
the areas of disability, homelessness, and drug use, as well 
members of the print media. 
Opening address
The opening address was given by writer and disability 
campaigner Sinéad Burke. Sinéad drew on her personal 
experiences of working with the media to highlight some 
of the key issues facing members of minority groups in 
getting their voices heard. While there is a lot of good and 
responsible reporting, she finds negative stereotypes continued 
to be perpetuated by the media. She talked about the 
unacceptability of what she termed ‘inspiration porn’, whereby 
the achievements and experiences of people with disabilities 
are used in the media to inspire non-disabled people. As 
the media has the power to inform people, it also has a 
responsibility to frame articles in an accurate and respectful 
way. 
Panel discussion
Presentations were made on three topics as part of the panel 
discussion.
Drug use
In February 2018, CityWide Drugs Crisis Campaign launched a 
campaign that focused specifically on the issue of stigma called 
‘Stop the Stigma: Addiction is a health issue not a crime’. Anna 
Quigley of CityWide outlined the theory underpinning the 
campaign.2 She made particular reference to how the media 
can perpetuate the stigma experienced by drug users. The use 
of pejorative language (in particular the term ‘junkie’) adds to 
an environment in which there is a lack of understanding of 
the complexities of addiction and the issues faced by people 
who use. Users are solely defined by their drug use rather than 
being seen as, for example, a mother or an employee. Even 
where the content of articles takes some consideration of the 
complexities and the challenges facing people who use drugs, 
the headlines can be stigmatising.
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Minority communities continued
Homelessness
Mike Allen of Focus Ireland highlighted the misrepresentation 
of people experiencing homelessness in the media. While only 
1% are rough sleepers, approximately 23% of the images used 
by the media when reporting on homelessness are of rough 
sleepers. Furthermore, the monthly homelessness figures 
tend to be accompanied by the same images, despite rough 
sleepers not being included in the figures. The impact of this 
misrepresentation includes that the wrong services are funded 
and that people experience stigma. If homelessness is equated 
with rough sleepers, then the service response is to build more 
emergency shelters and family hubs. However, if it is seen as 
a lack of a place to call home, then the response would be 
affordable secure homes.
Print media
There were recurring themes within the messages from the 
two media representatives: Neil Cotter, head of news at The 
Irish Sun and Niall Donald, news editor at the Sunday World. 
Both argued that their publications do not set out to cause 
harm to people, but they recognised that sometimes lines 
were crossed and lessons needed to be learned. The language 
within reporting was seen to be changing and both described 
‘junkie’ as unacceptable language in their publications. Despite 
this, it had appeared in some content. They felt the media 
was progressing in its understanding of its role when reporting 
on the issues under discussion and that there would be an 
openness to learn more through contact with advocacy groups.
Open discussion
There was a lively discussion, with contributions from a variety 
of advocacy groups representing the Travelling community, 
other minority ethnic groupings, and LGBTQ. A number of key 
messages came from it:
• Language matters. The use of pejorative language 
dehumanises people, adding to their stigmatisation. It 
prevents people from accessing services, their voice from 
being heard, and perpetuates a lack of understanding 
among decision-makers and the general public about the 
complexity and variation of people’s needs.
• The media should question the relevance of always 
reporting a person’s ethnicity when they are a member of 
a minority group. It was argued that this always happened 
when the story was negative, even though the person’s 
ethnicity was irrelevant to the story.
• While it is important that real-life stories are heard in 
the media, dealing with the media as an advocate can be 
problematic. It draws a lot of attention and judgement on 
the individual and can open them up to their story being 
unpicked. If people are to be asked to do this, then they 
need to be supported.
• While collaboration between advocacy groups was 
encouraged in educating the media about the issues faced, 
it was also highlighted ‘how different the differences are’. 
While homelessness is a chapter in someone’s life, being a 
Traveller is a fundamental identity. This would need to be 
acknowledged in any collaboration. 
• There is a need for greater representation of minority 
groups among those working in the media. 
• The issues facing minority groups and the role of the media 
should be covered in journalist courses. Training journalists 
at an early stage to consider the issues and identify sources 
of support would benefit everyone.
In conclusion
The Press Ombudsman concluded the event by welcoming the 
outcomes of the discussions. He highlighted the independent 
role of his office and noted that it is now easier than 10 years 
ago to make a complaint about the media and for it to be 
upheld. However, he noted that it is hard to uphold complaints 
about opinion pieces as his office has to balance freedom 
of expression and offence. He encouraged advocacy groups 
and members of the media to pursue a more collaborative 
approach to working together.
Lucy Dillon
1 For further information, visit:    
https://www.presscouncil.ie/about-us/recent-decisions-and-
news/“minority-communities-and-the-press”-seminar   
2 See Dillon L (2018) Reducing stigma in Ireland. Drugnet Ireland, 65: 
1–3. https://www.drugsandalcohol.ie/29093/
‘The voice of the 
street’
Public consultation was carried out as part of the development 
of Ireland’s current national drug strategy, Reducing harm, 
supporting recovery.1 In a bid to ensure that the voice of 
those most affected by the new strategy would be heard, the 
Union for Improved Services, Communication and Education 
(UISCE) carried out a consultation with people who use drugs 
(PWUD). While central to any drug policy, the stigmatisation 
and criminalisation of drug use are just two of the reasons why 
the voices of PWUD tend not to be heard in the policy-making 
process. A paper has been published on the ‘peer-led street 
outreach approach’ undertaken by UISCE to fill this gap. The 
paper provides valuable insights on how to engage with PWUD 
to inform policy development.2
Peer-led outreach
UISCE focused its efforts on what might be considered the 
most hard to reach of the cohort of PWUD in Ireland – those 
who are ‘injecting on the street’. The authors describe this 
as presenting a number of challenges: how to access these 
PWUD, ethical issues of safety and consent, and the logistical 
demands of carrying out the consultation in the time available. 
UISCE decided to build on its experience of taking a peer-led 
approach to its work, whereby PWUD use their knowledge 
and contacts to engage with other PWUD. Through this work, 
the views and experiences of 51 PWUD were included in the 
consultation. 
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Key issues in using this method of consultation:
• Prior to carrying out the consultation, UISCE had to address 
the ethical concerns of informed consent, confidentiality 
and safety. It did this by complying with various ethical 
frameworks that guide its work more broadly. 
• The research tool (a questionnaire designed by the 
Department of Health for the public consultation more 
broadly) needed to be adapted to be appropriate for 
PWUD. The wording was made more accessible through 
consultation with PWUD. 
• Success depended on how well-known the peer carrying 
out the recruitment was to the potential participants. 
Furthermore, reassurances were needed where PWUD 
were suspicious of others because of concerns, for 
example, about the police or drug debt. 
• The weather also presented a barrier to recruitment – 
people were less willing to complete the survey when it was 
cold and wet. 
Findings
Given the nature of the questionnaire as a broader public 
consultation document, the findings were limited in terms of 
depth. Findings included that 72% of PWUD identified heroin 
as the most harmful drug; 60% agreed that it was difficult to 
access treatment; and 68% were not aware of the existence 
of the 2009–2016 national drugs strategy. A full report of the 
findings is available from UISCE.3 
In conclusion
This consultation ensured that the voices of PWUD were 
heard in the development of the strategy; however, this 
paper highlights how time consuming a process it can be and 
the challenges faced. UISCE is represented on the National 
Oversight Committee and as such it might be expected that 
further consultation exercises of this kind will be undertaken 
to ensure the voices of PWUD are heard to inform the ongoing 
implementation of the strategy. 
Lucy Dillon
1 Department of Health (2017) Reducing harm, supporting recovery: 
a health-led response to drug and alcohol use in Ireland 
2017–2025. Dublin: Department of Health.    
https://www.drugsandalcohol.ie/27603/
2 Melaugh B and Rodrigues H (2018) ‘The voice of the street’: using 
peer led outreach with people who use drugs to inform the 
development of Ireland’s National Drug Strategy. Social Work and 
Social Sciences Review, 19(3): 7–16.    
https://www.drugsandalcohol.ie/29784/
3 UISCE (2016) Your voice: 2017 national drug strategy. Brass Munkie, 
30, Winter 2016
‘The voice of the street’ continued
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PREVALENCE AND CURRENT SITUATION 
Polydrug use in 
Ireland: 2014/15 
survey results
The National Advisory Committee on Drugs and Alcohol 
(NACDA) has recently published Bulletin 41 in a series of reports 
on the 2014/15 survey on drug use in the general population 
in Ireland.2 The bulletin focused on polydrug use in the adult 
population. Polydrug use was defined as the use of any two or 
more substances, legal, illegal or prescribed, within a one-
month period.
All adults
Twenty-three per cent of survey participants had not used 
any substance (either legal or illegal) within the last month. 
The most commonly used substance was found to be alcohol, 
with 32.7% reporting alcohol consumption in the month prior 
to the survey. The most common combination of substances 
in the population was found to be alcohol and tobacco (10.5% 
reporting use of both in the last month), and the percentage 
of those reporting the use of alcohol and other legal drugs was 
found to be 8.1%.
The combination of alcohol, tobacco and any illegal drug 
was 2%, which is higher than the proportion reporting use 
of tobacco and other legal drugs (1.1%), or alcohol and 
antidepressants (0.8%). All other combinations of polydrug use 
reported were 0.5% or less.
Gender
A higher percentage of females (26%) than males (20.3%) 
had not used any substance (legal or illegal) during the last 
month. A greater proportion of males consumed alcohol 
(36.8%) compared to females (28.7%), which was also true 
for the combination of alcohol and tobacco used in the last 
month (13.2% males vs 7.9% females). Males were also more 
likely to report the use of illegal drugs combined with alcohol 
and tobacco (3.2% males vs 0.8% females). However, a higher 
percentage of females reported that they had used alcohol with 
other legal drugs compared to males (9.2% vs 6.9%).
Age
The prevalence of alcohol and tobacco use in young adults 
aged 15-34 years was found to be 12.6%, which was higher than 
that reported by older adults aged 35-64 years (10.9%) and 
over 65s (4.3%). Polydrug use of alcohol and other legal drugs 
was found to be similar for younger and older adults (8.5% and 
8.7%, respectively), and lower in participants who were over 65 
years (5%).
In younger adults, illicit substances were most commonly used 
in combination with alcohol and tobacco (4.3%), while 0.9% of 
older adults reported this combination in the month before the 
survey. Older adults were more likely than younger adults to 
have used alcohol and antidepressants (1.4% vs 0.2%).
Relationship between use of particular 
substances and of other substances
Patterns of association between pairs of substances are 
presented in Table 1. For respondents who indicated using 
alcohol in the previous month, 30.2% had also used tobacco, 
while 5.9% had also used cannabis. A high percentage of 
people who used tobacco also reported the use of alcohol 
(71.5%), while 13.2% had also used cannabis and 7.7% also used 
antidepressants. Participants who indicated using cannabis 
in the month prior to the survey were also more likely to 
report alcohol use (87.4%) and/or tobacco use (82.9%), while 
20.2% of people who used cannabis also reported the use of 
amphetamine-type stimulants (ATS).
A majority of people who used ATS had also used alcohol 
(97.1%), tobacco (90.9%) and cannabis (87.4%), while 25.1% had 
also used cocaine. Among respondents who had used cocaine 
in the previous month, 83.6% had also used tobacco, 76.6% 
used cannabis, and one-half of people who used cocaine 
(50.1%) had also consumed ATS.
Since the 2010/11 survey, there has been a significant increase 
in the proportion of people who drink alcohol, who use 
tobacco, and who use cannabis among people who use ATS 
(+1.4, +3.1 and +18.0 percentage points, respectively). The 
proportion of those who used alcohol, tobacco or cocaine 
in the last month, and who also reported using cannabis, has 
also increased significantly since 2010/11 (+2.6, +5.6 and +35.7 
percentage points, respectively).
Other findings
Other main findings from the NACDA survey include the 
following:
• Among people who use alcohol, males are more likely than 
females to have smoked tobacco (33.5% vs 26.2%) in the 
last month, or to have used cannabis (8.3% vs 3.1%).
• The proportion of males who use cannabis and who also 
report the use of cocaine is almost double that of females 
(10.0% vs 5.4%).
• Since 2010/11, the proportion of people who use tobacco, 
and who also use alcohol, has decreased significantly for 
males and females (from 83.1% to 76.7% in males and from 
72.5% to 64.9% in females), while the percentage of people 
who use tobacco, and who also use cannabis, has increased 
significantly (from 11.2% to 17.6% in males and 3.1% to 7.7% 
in females).
• The proportion of respondents who use sedatives or 
tranquillisers and who also use antidepressants has 
increased since the 2010/11 survey (+6.8 percentage points). 
Similarly, the proportion of those using antidepressants 
who also use sedatives or tranquillisers has increased by 4.6 
percentage points.
Seán Millar
1 National Advisory Committee on Drugs and Alcohol (NACDA) and 
Department of Health (UK) (2018) 2014/15 Drug prevalence survey: 
polydrug and new psychoactive substances results. Bulletin 4. 
Dublin: NACDA. 
2 National Advisory Committee on Drugs and Alcohol (NACDA) and 
Department of Health (UK) (2016) Prevalence of drug use and 
gambling in Ireland and drug use in Northern Ireland. Bulletin 1. 
Dublin: NACDA. https://www.drugsandalcohol.ie/26364/ 
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Method by which cannabis is used
Survey respondents were asked about the most common 
method used to take cannabis (Table 3). The most common 
method reported was smoking a joint (96.2%), while 2% said 
they used a pipe. Results by gender show that smoking joints 
was the most common method reported by females (94.8%), 
while 3.1% of females reported eating cannabis. Smoking joints 
was also the most common method reported by males (96.7%), 
followed by a pipe (2.6%) and a bong (0.7%). In terms of age, 
smoking joints was the method used by a majority of young 
adults (96.3%) and older adults (95.9%) who used cannabis, 
while using a pipe was more likely to be reported by older 
adults than young adults (4.1% vs 1.5%).
Other findings
Other main findings from the NACDA survey include the 
following:
• The majority of people who used cannabis in the last 
year reported that it would be easy or very easy to obtain 
cannabis in a 24-hour period (87.1%), with 2.6% reporting 
that it would be difficult or very difficult.
• Respondents who had used cannabis regularly at some 
point in their lifetime were also asked about attempts to 
stop. Of this group, 72.1% said they had managed to stop 
and 7.4% stated they had tried without success.
• Most respondents (74.5%) agreed that people should be 
permitted to take cannabis for medical reasons. Males were 
more likely to agree with this statement than females (77% 
vs 72.1%). Older adults were more likely to agree than young 
adults (78.4% vs 73.9%) and over 65s (64.2%).
• A majority of survey respondents disagreed with the 
recreational use of cannabis (66.4%) and 74.3% disapproved 
of people smoking cannabis occasionally.
• Lifetime rates of cannabis use were highest among people 
who were in middle management, senior civil servants, 
managers, and business owners at 28.7%. Last-year and 
last-month rates were highest among semiskilled and 
unskilled manual workers, trainees and apprentices, with 
8.4% having used cannabis in the last year and 5.9% in the 
last month. 
• Lifetime rates for cannabis use were highest in the group 
classified as ‘renting from a private landlord’ (38.9%). Last-
year and last-month rates were highest for those living with 
their parents/other family (14.2% and 8.6%, respectively). 
Cannabis abuse was highest for those living with parents/
other family (4.9%), and 4.3% met the criteria for cannabis 
dependence.
• The results show that levels of cannabis use increase with 
education. Lifetime rates were highest among those who 
ceased education at 20 years of age and over and among 
those with a third-level education. Rates were lowest 
among those who ceased education at 15 years or under 
and among those with primary-level education only. 
Conversely, rates of cannabis abuse and dependence were 
found to be highest among those who ceased education 
aged 15 or under (2.2% and 1.5%, respectively).
• Lifetime, last-year and last-month rates were highest 
among those classified as cohabiting or single.
Cannabis use in 
Ireland: new findings 
from the fourth 
general population 
survey
The National Advisory Committee on Drugs and Alcohol 
(NACDA) has recently published Bulletin 31 detailing findings 
from the fourth drug prevalence survey regarding the use 
of cannabis in Ireland.2 This survey followed best practice 
guidelines and used a random sample of households 
throughout the island of Ireland. Of the household members 
contacted, 7,005 agreed to take part. The sample was weighted 
by gender, age and region to ensure that it was representative 
of the general population. This article highlights major findings 
from this bulletin.
Age at first use and age at first regular use
The median age of first use of cannabis in the Republic of 
Ireland was found to be 18 years for those who reported ever 
having used cannabis in their lifetime. The median age for 
males, females and young adults was also 18 years, and slightly 
higher for older adults (19 years) and over 65s (25 years). Among 
those who said that they had regularly used cannabis at some 
point in their lives, the median age of first use was 17 years; 
this was the case for both males and females and is unchanged 
since 2010/11. The median age of first use was found to be 17 
years for young adults (compared to 16 years in 2010/11) and 
was also 17 years for older adults (compared to 18 years in 
2010/11). The median age of first use was found to be 20 years 
for adults aged over 65 years. The period of time between first 
using cannabis and regular use was one year for all adults. 
Cannabis dependence and cannabis abuse
Among people who used cannabis in the last year, 19.7% fulfilled 
the criteria for cannabis dependence (Table 1). The rate was 
higher for males (22.8%) than for females (11.8%) and higher for 
young adults (22.3%) than for older respondents (10.4%). 
In the general population, 1.5% of those aged 15+ were classed 
as cannabis dependent. This rate was found to be significantly 
higher in males (2.5%) than females (0.5%), and also significantly 
higher in young adults (3.6%) than older subjects (0.4%). Over 
65s reported no cannabis dependence or abuse.
Type of cannabis most commonly used
Participants were asked to state what type of cannabis they 
most commonly used. The possible options and their relevant 
frequencies are shown in Table 2. The results demonstrate 
that almost 50% of those who used cannabis in the last month 
reported using ‘weed’; 28.1% used ‘grass’; 2% used ‘herb’; and 
2% had used ‘skunk’. Resin was reported by 16.3% of people 
who used cannabis in the last month and the types mentioned 
were ‘hash’ (14.9%) and ‘resin’ (1.4%). 
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Seán Millar
1 National Advisory Committee on Drugs and Alcohol (NACDA) and 
Department of Health (UK) (2017)  2014/15 Drug prevalence survey: 
cannabis results. Bulletin 3. Dublin: NACDA. 
2 National Advisory Committee on Drugs and Alcohol (NACDA) and 
Department of Health (UK) (2016) Prevalence of drug use and 
gambling in Ireland and drug use in Northern Ireland. Bulletin 1. 
Dublin: NACDA. https://www.drugsandalcohol.ie/26364/
Table 1: Cannabis dependence and cannabis abuse among people who used cannabis in the last year and among the general population
 All adults 
(15+ years) 
(%)
Male
 (15+ years) 
(%)
Female 
(15+ years) 
(%)
Young adults
(15-34 years) 
(%)
Older adults
(35-64 years) 
(%)
65+ years 
(%)
People who used in the last year
Total weighted N 
(valid responses)
458 330 128 357 101 0
Cannabis dependence 19.7 22.8 11.8 22.3 10.4 0.0
Cannabis abuse 30.3 33.0 23.5 32.3 23.5 0.0
General population
Total weighted N 
(valid responses)
7005 3439 3566 2592 3345 0
Cannabis dependence 1.5 2.5 0.5 3.6 0.4 0.0
Source: NACDA, 2017
Table 2: Type of cannabis commonly used among people who used in the last month by gender, 2006/07, 2010/11 and 2014/15
 All adults 
(15-64 years)
(%)
Male
(15-64 years)
(%)
Female
(15-64 years)
(%)
06/07 10/11 14/15 06/07 10/11 14/15 06/07 10/11 14/15
Total weighted N 
(valid responses)
128 143 259 99 119 196 28 24 63
Hash 53.8 22.6 14.9 50.3 23.5 15.4 66.2 18.3 13.2
Grass 26.8 21.8 28.1 27.8 19.9 28.4 23.5 30.9 27.1
Resin 6.4 4.2 1.4 6.7 3.8 1.6 5.2 6.0 0.8
Weed 8.4 46.5 49.6 10.1 49.0 48.9 2.5 33.9 51.8
Herb 1.9 0.0 2.0 2.5 0.0 1.3 0.0 0.0 4.2
Skunk 1.2 2.4 2.0 1.6 2.5 2.6 0.0 2.1 0.0
Hash oil 0.8 0.7 0.3 1.1 0.5 0.5 0.0 2.1 0.0
Don't know 0.6 1.7 0.5 0.0 0.7 0.7 2.6 6.8 0.0
Source: NACDA, 2017
Table 3: Method of taking cannabis among people who used in the last month
 All adults 
(15+ years)
(%)
Male
 (15+ years)
(%)
Female 
(15+ years)
(%)
Young adults
(15-34 years)
(%)
Older adults
(35-64 years)
(%)
65+ years
(%)
Total weighted N 
(valid responses)
259 196 63 210 49 0
Joint 96.2 96.7 94.8 96.3 95.9 0.0
Pipe 2.0 2.6 0.0 1.5 4.1 0.0
Bong 0.8 0.7 1.0 1.0 0.0 0.0
Eat 0.8 0.0 3.1 0.9 0.0 0.0
Refused 0.3 0.0 1.0 0.3 0.0 0.0
Source: NACDA, 2017
Cannabis use in Ireland   
continued
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9 without a prescription but also illegal to supply or sell them to 
another person. Class C controlled drugs in the UK cannot be 
dispensed using an electronic prescription but require a doctor 
to physically sign the prescription. They also must be dispensed 
within 28 days from the date of prescribing.
In Ireland, data from the National Drug-Related Deaths Index 
show there has been a notable increase in the number of 
poisoning deaths where pregabalin has been implicated, from 
26 in 2014 to 44 in 2015, a jump of 69%.3
Suzi Lyons
1 Home Office (2018) Pregabalin and gabapentin to be controlled as 
class C drugs. London: Home Office.  
 https://www.gov.uk/government/news/pregabalin-and-
gabapentin-to-be-controlled-as-class-c-drugs
2 Home Office (2018) A consultation on proposals to schedule 
pregabalin and gabapentin under the Misuse of Drugs Regulations 
2001. Government response to the consultation. London: Home 
Office.       
https://assets.publishing.service.gov.uk/government/uploads/
system/uploads/attachment_data/file/748439/consultation-
response-pregabalin-gabapentin.pdf
3 Health Research Board (2017) National Drug-Related Deaths Index 
2004 to 2015 data. Dublin: Health Research Board.  
https://www.drugsandalcohol.ie/28086/
Pregabalin and 
gabapentin 
reclassified as 
controlled drugs in 
the UK
In October 2018, the United Kingdom (UK) reclassified 
pregabalin and gabapentin as class C controlled drugs, which 
will come into force in April 2019.1 This is in direct response to 
the increased number of deaths linked to both these drugs in 
the UK and a consultation process around this issue.2 
Speaking of the announcement, the British Minister for Crime, 
Safeguarding and Vulnerability Victoria Atkins MP stated: ‘Any 
death related to the misuse of drugs is a tragedy. We accepted 
expert advice and will now change the law to help prevent 
misuse of pregabalin and gabapentin and addiction to them.’
What this means is that it will be illegal to possess these drugs 
Rise in first-time 
treatment admissions 
for older adults who 
use opioids
International agencies such as the United Nations and the 
European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA) have recently highlighted their concerns about 
increased drug use among older people.1,2 An Irish study 
published in the journal, Drug and Alcohol Dependence, 
demonstrates that the proportion of older people starting 
treatment for opioid use is growing, and many have used opioid 
drugs for a relatively long time prior to seeking treatment.3
The study analyses data from the National Drug Treatment 
Reporting System (NDTRS) over the 19-year period from 1996 
to 2014 inclusive. The NDTRS is an epidemiological database 
on treated problem drug and alcohol use in Ireland. Treatment 
records where an individual started treatment for the first time 
and an opioid was the primary drug problem were selected and 
the data were explored using statistical techniques to assess 
changes over time.
A total of 18,692 individuals entered treatment for the first 
time for opioid use during the study period. The number of 
treatment admissions peaked in 2009, with numbers declining 
in subsequent years. Heroin was the main problem opioid 
across all years, accounting for 92.7% (n=17331) of all treatment 
entries, while methadone accounted for 2.2% (n=417), over-
the-counter and other prescribed opioids accounted for 4.6% 
(n=852) of treatments. A small number of other opioid types 
were reported (0.5%, n=92), including opium and unspecified 
opioid drugs.
Population figures were used to calculate annual treatment 
incidence rates, which were analysed for trends over time. 
Trends in admissions fluctuated across the period and several 
significant trends were observed. Overall, age-adjusted 
treatment incidence has declined over the last 18 years. 
Significant downward trends were observed in age-adjusted 
rates for the years 1996−2004, with an annual percentage 
change (APC) of −7.0% (CI: −10.1 to −3.9, p=0.003), and also in 
the period 2009−2014 (APC=−8.6, CI: −14.6 to −2.9, p=0.012). 
However, in the interim years (2004−2009), the trend was 
upward and significant (APC=13.4, CI: 3.1−24.9, p=0.012).
The examination of incidence by age revealed a downward 
trend among younger age groups and an upward trend among 
older age groups. In early years (1996−2002), incidence was 
concentrated among younger age groups and became more 
dispersed as time passed. The largest significant downward 
trends were observed among 15−19-year-olds in the years 
2009−2014 (APC=−25.0, CI: −36.2 to −11.9, p<0.001) and among 
20−24-year-olds in the years 2010−2014 (APC=−12.9, CI: −21.5 
to −3.3, p<0.001). Upward trends were detected among older 
age groups, and two groups were evident: (1) incidence was low 
in early years among those aged 25−49 years and increased 
by varying amounts, and (2) there was a rising incidence that 
did not previously exist among 50−74-year-olds. The largest 
significant upward trends were among 35−39-year-olds in the 
years 2003−2009 (APC=27.4, CI: 9.2−48.6, p=0.003), and also 
among 40−44-year-olds (APC=14.6, CI: 10.7−18.6, p<0.001) and 
45−49-year-olds (APC=13.6, CI: 9.2−18.1, p<0.001) right across 
the study period. 
Other key findings
Other key findings from the study included the following:
• The results show evidence of subgroups within the 
treatment population; those who seek treatment quickly 
and also those who take much longer to seek treatment. 
There is evidence of late-onset drug users – individuals who 
begin drug use later in life. 
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• The profile of people entering treatment for opioid use has 
changed; people are now older, are injecting for longer, and 
are taking longer to enter treatment. 
       – The median age commencing opioid use increased by 3 
years (from age 18 to age 21 ) (U=326141.5, p<0.001). 
       – The median age entering treatment increased by 11 years 
(from age 20 to age 31) (U=145465.5, p<0.001). 
       – The median opioid-using duration prior to treatment 
increased by 5 years (from 2 to 7 years) (U=170807.5, 
p<0.001). 
       – One-half of the individuals started injecting within 1 year 
of first using opioids. The median time between first 
injecting and commencing treatment increased by 6 
years for men and 2 years for women.
The study authors highlight that: 
• In recent years, more and more people aged 50 years and 
older are entering treatment for opioid use, a trend not 
previously observed. 
• Results show how service need has changed over the last 
two decades and provide an indication of future service 
need, which is essential for planning purposes. These 
findings also highlight how treatment data can be used to 
identify hidden groups at risk of chronic harm which may 
require prioritising in policy and practice. 
Older adults who use opioids 
continued
The authors note that although drug treatment data are 
collected across 30 European countries, this study is the first 
large-scale examination of ageing and opioid use trends. The 
study provides evidence to underpin policy development 
and changes in practice. Current drug policies and treatment 
services are predominately focused on the needs of the known 
profile of younger drug users, and it is inevitable that existing 
services need to adapt to the ageing population. The changing 
composition of this group suggests a wide range of services 
will be required into the future and integrated approaches 
across addiction and healthcare services would be beneficial in 
identifying and treating addiction problems among ageing drug 
users. 
Anne Marie Carew
1 United Nations Office on Drugs and Crime (UNODC) (2018) World 
drug report 2018. Vienna: United Nations.   
https://www.drugsandalcohol.ie/29252/ 
2 European Monitoring Centre for Drugs and Drug Addiction (2017) 
Health and social responses to drug problems: a European guide. 
Luxembourg: Publications Office of the European Union.  
https://www.drugsandalcohol.ie/28040/ 
3 Carew AM and Comiskey C (2018) Rising incidence of ageing 
opioid users within the EU wide treatment demand indicator: 
the Irish opioid epidemic from 1996 to 2014. Drug and Alcohol 
Dependence, 192: 329–337.     
https://www.drugsandalcohol.ie/29783/
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RESPONSES 
The place of drug 
education in 
Ireland’s response 
to drug use
A recent paper examines the position of drug education 
workers who work with children and young people in non-
formal education settings in Ireland.1 Drug education is 
described in the article as ‘a range of interventions across 
multi-disciplinary settings and includes education programmes, 
policies and guidelines’. While not unpacked in the paper, the 
author highlights that the terms ‘drug prevention’ and ‘drug 
education’ are often used interchangeably but they are distinct 
activities. Drug prevention’s primary aim is to change people’s 
behaviour around drug use, whereas drug education is more 
about delivering factual information about drugs to people.2 
This article is only interested in the latter.
Research and analysis
There are three main strands to the author’s research and 
analysis.
Origins of drug education in Ireland 
In 1974, the Committee on Drug Education recommended that 
drug education should be included as part of a broad health 
education programme to be delivered in schools. The author 
describes the development of drug education programmes 
as ‘slow’ (p. 363) but the introduction of programmes such 
as On My Own Two Feet and the Social, Personal and Health 
Education (SPHE) curriculum meant that the provision of drug 
education for children and young people was ‘placed firmly’ (p. 
363) within the remit of the formal education sector. However, 
there was also scope for it to be delivered within non-formal 
education settings. When local and regional drug and alcohol 
task forces were established (late 1990s and early 2000s, 
respectively), funding was made available for drug education 
workers. The provision of community-based drug awareness 
programmes was reinforced by the national drugs strategy that 
ran from 2001 to 2008 (p. 62).3 
Development and demise of Drug Education Workers 
Forum 
The Drug Education Workers Forum (DEWF) was established 
in 2000 as a voluntary organisation. Among its aims were 
to provide drug education workers with the opportunity to 
network, exchange drug-related information, and influence 
policy through the forum’s collective voice. As part of its work 
in 2007, it published A manual in quality standards in substance 
use education (QSSE)4 – this was ‘an overarching framework 
and guidelines for practitioners of drug education and those 
commissioning drug education programmes’ (p. 364). The start 
of the recession in 2007, however, meant cuts to funding and a 
redeployment of staff. The author argues that this resulted in a 
significant reduction of drug education workers being funded 
by the task forces, and ultimately led to the demise of the 
DEWF. While an evaluation of the QSSE was published in 2013, 
the author describes drug education workers as being ‘largely 
voiceless at national platforms’ since then (p. 365).
Drug education as part of response to illicit drug use 
Secondary analysis of the three national drug strategies 
covering the period 2001 to 2018 was carried out, along with 
the 2016 annual reports from the local and regional drug 
and alcohol task forces. The purpose was to explore the 
prominence of drug education workers in the national response 
to drug use, and an estimation of the numbers working in the 
field. The overall picture was one in which drug education as 
such has become a less prominent feature of the strategic 
response. The author describes a ‘sheer absence’ (p. 368) of 
references to drug education in the current national drugs 
strategy (2017–2025),5 other than one within the context of 
harm reduction activities. He also identifies the number of 
drug education workers within the local and regional drug 
and alcohol task forces as ‘very low’ (p. 370). It is important to 
note however that many of those working in the task forces in 
prevention rather than drug education as such will be delivering 
drug education as part of their work. 
Conclusion
The author concludes that drug education as a field in Ireland 
has diminished over time and workers are in a precarious 
position. While he acknowledges that this may partly be due 
to a lack of evidence of its effectiveness as a form of drug 
prevention, he argues that the efficacy and effectiveness of 
drug education should be measured in an education rather 
than a prevention framework. This would make it possible 
to ‘measure the learning that takes place in drug education 
programmes and document the educational benefit to 
participants’ (p. 371). However, the author does not provide 
further evidence of why these specific outcomes are important 
within the context of a national response to illicit drug use. 
Therefore, while drug education is ongoing in Ireland within the 
broader contexts of prevention and harm reduction activities, 
it would be interesting to have clarified why educational 
outcomes alone are of value as this is not suggested as a 
priority internationally.2
Lucy Dillon
1 Darcy C (2018) The precarious position of drug education workers 
in Ireland. Economic and Social Review, 49(3): 361–372.  
https://www.drugsandalcohol.ie/29721/
2 See for example Warren F (2016) ‘What works’ in drug education 
and prevention? Edinburgh: Scottish Government.  
https://www.drugsandalcohol.ie/26557/
3 Department of Tourism, Sport and Recreation (DoTSR) (2001) 
Building on experience: national drugs strategy 2001–2008. 
Dublin: Stationery Office. https://www.drugsandalcohol.ie/5187/ 
4 Drug Education Workers Forum (DEWF) (2007) A manual in quality 
standards in substance use education. Dublin: Drug Education 
Workers Forum. https://www.drugsandalcohol.ie/6339/  
5 Department of Health (2017) Reducing harm, supporting recovery: 
a health-led response to drug and alcohol use in Ireland 
2017–2025. Dublin: Department of Health.    
https://www.drugsandalcohol.ie/27603/
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 3  EUPC for workplace and family-based prevention.
The earlier part of day 2 looked more closely at the training 
component of EUPC and which conclusions did the pilot 
deliver. This portion of the day contained presentations on 
the training of decision, opinion and policy makers (Rachele 
Donini, ASL 2 Savonese); the online version of training (Roman 
Gabrhelík, Charles University); and the academic version 
(Martina Ferić, University of Zagreb). The second part of the day 
focused on next steps and the dissemination of EUPC across 
Europe. 
The curricula developed by UPC-Adapt are an interesting 
proposal in the Irish context. A recent article2 examined the 
prominence of drug education work within the statutory 
response to drug use in Ireland. The author argues that drug 
education is underfunded, and without national representation 
since the disbanding of the Drug Education Workers Forum 
(DEWF). The precarious position might be explained by question 
marks over the perceived value of drug education. A HRB Drug 
and Alcohol Evidence Review3 highlighted a lack of good-
quality evaluation in the field: ‘When considering the current 
state of the evidence and the accompanying evidence gaps, 
it is worth noting that the absence of evidence should not be 
taken as evidence of absence’ (p. 36). Coupled with a lack of 
rigorous research, expectations of drug education are often 
unrealistic and contradictory. These factors have combined 
to create the conditions for bad practice in drug education 
to not only survive but to thrive. EUPC offers the potential 
to improve practice with regard to drug prevention and to 
convince decision, opinion and policy makers of the value of 
evidenced practice, and a firmer footing for those working as 
drug education and prevention practitioners.
Richie Stafford
1 For further information on UPC-Adapt, visit: http://upc-adapt.eu/ 
2 Darcy C (2018) The precarious position of drug education workers 
in Ireland. Economic and Social Review, 49(3): 361–372.  
https://www.drugsandalcohol.ie/29721/ 
3 Munton T, Wedlock E and Gomersall A (2014) The efficacy and 
effectiveness of drug and alcohol abuse prevention programmes 
delivered outside of school settings. HRB Drug and Alcohol 
Evidence Review 2. Dublin: Health Research Board.  
https://www.drugsandalcohol.ie/23079/ 
Reitox Academy on 
Universal Prevention 
Curriculum (UPC-
Adapt) 
This Reitox Academy was organised by the European Monitoring 
Centre for Drugs and Drug Addiction (EMCDDA) and the UPC-
Adapt Group1 in collaboration with the First Faculty of Medicine, 
Charles University in Prague, and the Czech National Monitoring 
Centre for Drugs and Addiction, within the framework of 
the final conference of the Universal Prevention Curriculum 
(UPC)-Adapt project, funded with the support of the European 
Commission. It took place on 28–29 November 2018 at the 
Lichtenstein Palace in Prague.
The UPC-Adapt generated a set of curricula for application in 
training of prevention professionals in Europe. Nine European 
Union (EU) member states (Belgium, Czech Republic, Croatia, 
Estonia, Germany, Italy, Poland, Slovenia and Spain) piloted 
these materials in 2018. Given the significance of the work and 
interest in the topic among the experts in the EU member 
states and beyond, the EMCDDA together with the UPC-Adapt 
project will extend the beneficiaries of the project through 
train-the-trainer events and other activities planned in 2019. 
The Reitox Academy was organised to present the results of 
the work done and to discuss the possible dissemination of the 
programmes across Europe.
The objectives of the academy were to: (1) increase 
understanding of the European UPC’s (EUPC) potential and 
the motivation of the Reitox partners to launch the EUPC in 
their respective countries; (2) provide a short introduction 
and an overview of the EUPC and to motivate participation 
in future train-the-trainer events; and, (3) explore liaison with 
universities that implement the full UPC within their academic 
syllabi. The conference was also an excellent opportunity 
to network with prevention practitioners and learn from 
approaches and initiatives across Europe.
Conference agenda
The conference was attended by nominees from 21 EU member 
states and potential candidate countries to the EU. Day 1 of the 
conference opened with plenary presentations from Gregor 
Burkhart (EMCDDA) on what works in drug prevention and from 
Peer van der Kreeft (University College Ghent) on the history 
of the UPC-Adapt project and core issues in the adaptation 
process. 
Three parallel workshops on the ‘Content and method of EUPC 
training’ were held in the afternoon. The group was split into 
three, covering the following topics:
 1  EUPC for school-based and community-based   
    prevention
 2  EUPC for environmental and media-based prevention
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latest strategic plan 
on 20th anniversary 
of service
On 14 November 2018, the Chrysalis Community Drug and 
Alcohol Team, led by Passerose Mantoy-Meade, launched their 
strategy plan for 2019-2021. At the same event, they celebrated 
20 years providing a range of drug and alcohol services in 
Dublin's north inner city. Master of ceremonies was Dr Des 
Crowley, who is also chair of the Chrysalis board of directors. 
The event was attended by many past clients of Chrysalis and 
representatives of other services.
Dr Crowley introduced the event and Passerose Mantoy-Meade 
gave an emotional and heartfelt speech about the work of 
Chrysalis and how it had grown to meet the challenges of those 
with drug and alcohol problems in their community.  
Dr Suzi Lyons from the Health Research Board gave an 
overview of drug treatment trends over the past 20 years.  
Colman Ronayne from Chrysalis gave an insight into what case 
management really means. Michael McGoldrick, pharmacist 
from the Mews Clinic, spoke of the cooperation between the 
Health Service Executive and Chrysalis and how they worked 
to meet the needs of the clients. Dr Marguerite Woods spoke 
about trauma-informed practice, while Eamonn Geoghegan 
from Chrysalis gave an overview of the peer-led initiatives in 
the service. Finally, Wendy Lyon spoke about human rights and 
sex work.
Chrysalis already offers a wide range of services, ranging from 
harm reduction, early intervention, case management and 
integrated care planning to, counselling and aftercare. Its new 
strategy looks to extend the range of services offered and has 
a new team leader to support the key workers, peer works, and 
therapists currently providing care to Dublin's north inner city.
Suzi Lyons
Dr Des Crowley, chair of 
the Chrysalis board of 
directors, and Passerose 
Mantoy-Meade, 
Chrysalis Community 
Drug and Alcohol Team, 
at the launch of the 
strategy plan (Photo:  
Derek Speirs)
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Recent publications
The following abstracts are cited from published journal articles 
recently added to the repository of the HRB National Drugs 
Library at www.drugsandalcohol.ie 
PREVALENCE AND CURRENT SITUATION
Rising incidence of ageing opioid users within the EU wide 
treatment demand indicator: The Irish opioid epidemic from 
1996 to 2014
Carew AM and Comiskey C (2018) Drug and Alcohol 
Dependence, 192: 329–37.
https://www.drugsandalcohol.ie/29783/ 
Literature identifies older people who use opioids as a 
neglected population. Little is known about temporal changes, 
or about treatment demand among this population. The EU 
Treatment Demand Indicator (TDI) for Ireland (1996–2014) was 
analyzed for trends in new opioid treatment admissions, ageing 
and drug using behaviors. A Joinpoint analysis was conducted.
The study utilizes European TDI data and finds that those 
entering treatment in Ireland is older, are injecting longer and 
are taking longer to enter treatment. These findings highlight 
how TDI data can be used to identify hidden groups at risk 
of chronic harm which may require prioritizing in policy and 
practice.
‘The voice of the street’: using peer led outreach with 
people who use drugs to inform the development of Ireland’s 
National Drug Strategy
Melaugh B and Rodrigues H (2018) Social Work and Social 
Sciences Review, 19(3): 7–16.
https://www.drugsandalcohol.ie/29784/ 
The purpose of this article is to share how an Irish drugs 
advocacy organisation, UISCE conducted a consultation with 
‘People Who Use Drugs’ (PWUD) to inform the development of 
Ireland’s National Drugs Strategy: Reducing Harm Supporting 
Recovery. People who use drugs are considered a ‘hard to 
reach’ or ‘hidden’ population’ who, because of their marginal 
status, are often absent from research and drug policy. 
Indeed, there is a lack of published data on how to engage 
with PWUD to inform policy development. The paper aims to 
extend the literature by highlighting how UISCE, employing a 
‘peer-led street outreach’ approach, included 51 PWUD in the 
consultation to inform the Irish national drug strategy. Central 
to the paper is a description of the steps taken to conduct the 
consultation with a review of the challenges and benefits of 
using a ‘street based recruitment’ strategy to engage with hard 
to reach people who use drugs.
Prevalence of smoking and provision of smoking cessation 
advice during hospitalization
Najeeb N, Halawani M, McElvaney NG and Doyle F (2018) Irish 
Medical Journal, 111(9): 821.
https://www.drugsandalcohol.ie/29809/
We aimed to determine the prevalence of smoking and smoking 
cessation advice received by inpatients in Beaumont Hospital 
and compared results to previous similar studies.
There remains limited provision of smoking cessation advice to 
inpatients.
Symptom-triggered therapy for assessment and 
management of alcohol withdrawal syndrome in the 
emergency department short-stay clinical decision unit
Ismail MF, Doherty K, Bradshaw P, O'Sullivan I and Cassidy EM 
(2018) Emergency Medicine Journal, 36(1): 18–21.
https://www.drugsandalcohol.ie/29777/ 
In this study, we aim to describe the feasibility of symptom-
triggered therapy (STT) in an emergency department (ED) 
short-stay clinical decision unit (CDU) setting.
STT is potentially feasible as a rapid and effective approach to 
managing alcohol withdrawal syndrome in the ED/CDU short-
stay inpatient setting where patient LOS is generally less than 
24 hours.
Alcohol use and burden for 195 countries and territories, 
1990–2016: a systematic analysis for the Global Burden of 
Disease Study 2016
GBD 2016 Alcohol Collaborators (2018) Lancet, 392(10152): 
1015–35.
https://www.drugsandalcohol.ie/29555/ 
With our comprehensive approach to health accounting within 
the Global Burden of Diseases, Injuries, and Risk Factors Study 
2016, we generated improved estimates of alcohol use and 
alcohol-attributable deaths and disability-adjusted life-years 
(DALYs) for 195 locations from 1990 to 2016, for both sexes and 
for 5-year age groups between the ages of 15 years and 95 
years and older.
National Drugs Library
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The precarious position of drug education workers in Ireland 
Darcy C (2018) Economic and Social Review, 49(3): 361–72.
https://www.drugsandalcohol.ie/29721/ 
This article examines the position of drug education workers 
who deliver drug education in non-formal education settings 
to children and young people in Ireland. Employing secondary 
data and document analysis, the paper analyses three national 
drug strategies and the annual reports of 21 local and regional 
Drug and Alcohol Task Forces (DATFs), in order to determine 
the prominence of drug education workers within the statutory 
response to illicit drug use in Irish society.
Presentations to the emergency department with non-
medical use of benzodiazepines and Z-drugs: profiling and 
relation to sales data
Lyphout C, Yates C, Margolin ZR, Dargan PI, Dines AM, 
Heyerdahl F, et al. (2019) European Journal of Clinical 
Pharmacology, 75(1): 77–81.
https://www.drugsandalcohol.ie/29713/ 
The aim of this paper is to describe presentations to the 
emergency department in Europe related to the recreational 
use of benzodiazepines and Z-drugs and compare regional 
differences in these presentations with legal drug sales of 
benzodiazepines and Z-drugs within each country.
Health status of the homeless in Dublin: does the mobile 
health clinic improve access to primary healthcare for its 
users? 
Swabri J, Uzor C, Laird E and O'Carroll A (2018) Irish Journal of 
Medical Science, Early online.
https://www.drugsandalcohol.ie/29635/ 
This paper aims to explore and determine the specific health 
reasons for attending the mobile health unit and to investigate 
whether the MHC (mobile health clinic) improves access to 
primary healthcare for homeless people.
While the findings of this study are limited by the small sample 
size, they nevertheless indicate that the MHC promotes access 
to primary care service. Results also highlight the need to 
expand the healthcare approaches on the MHC to adequately 
meet the health needs of its target population.
Socio-demographic, health and lifestyle factors influencing 
age of sexual initiation among adolescents 
Burke L, Nic Gabhainn S and Kelly C (2018) International Journal 
of Environmental Research and Public Health, 15(9): 1851.
https://www.drugsandalcohol.ie/29613/ 
This research explores relationships between contextual socio-
demographic, health and lifestyle factors and the timing of first 
sexual intercourse among 15–17-year-olds in Ireland.
The study found that initiation of risk behaviours such as 
smoking, alcohol use, drunkenness or cannabis at younger ages 
was predictive of early sexual initiation among girls and boys.
Alcohol use is a leading risk factor for global disease burden 
and causes substantial health loss. We found that the risk 
of all-cause mortality, and of cancers specifically, rises with 
increasing levels of consumption, and the level of consumption 
that minimises health loss is zero. These results suggest that 
alcohol control policies might need to be revised worldwide, 
refocusing on efforts to lower overall population-level 
consumption.
Global, regional, and country-level estimates of hepatitis C 
infection among people who have recently injected drugs
Grebely J, Larney S, Peacock A, Colledge S, Leung J, Hickman 
M, et al. (2019) Addiction, 114(1): 150–66.
https://www.drugsandalcohol.ie/29394/ 
This study estimated the prevalence and number of people with 
recent injecting drug use living with HCV, and the proportion 
of people with recent injecting drug use among all people living 
with HCV infection at global, regional, and country-levels.
Although, globally, 39.2% of people with recent injecting drug 
use are living with hepatitis C virus (HCV) and 8.5% of all HCV 
infections globally occur among people with recent injecting 
drug use, there is wide variation among countries and regions. 
Borderline personality disorder: resource utilisation costs in 
Ireland
Bourke J, Murphy A, Flynn D and Kells M (2018) Irish Journal of 
Psychological Medicine, Early online.
https://www.drugsandalcohol.ie/29512/ 
The objective of this study is to determine the use of direct 
health care resources by persons with BPD in Ireland and the 
corresponding costs.
There is a dearth of data on health care resource use and costs 
of community mental health services in Ireland. The absence of 
this data is a considerable constraint to research and decision-
making in the area of community mental health services. This 
paper contributes to the limited literature on resource use 
and costs in community mental health services in Ireland. 
The absence of productivity loss data (e.g. absenteeism and 
presenteeism), non-health care costs (e.g. addiction treatment), 
and indirect costs (e.g. informal care) from study participants is 
a limitation of this study.
It's not all about price: factors associated with roll-your-own 
tobacco use among young people – a qualitative study
Breslin E, Hanafin J and Clancy L (2018) BMC Public Health, 18(1): 
991. https://www.drugsandalcohol.ie/29424/ 
Smoking prevalence in Ireland is falling in all age groups, but 
the prevalence of roll-your-own (RYO) tobacco use is rising 
among young people. This qualitative study aims to explore and 
understand the factors associated with young people's use of 
RYO products.
While the lower cost of RYO products is very important for 
young smokers, other product characteristics and influences 
also incentivise and disincentivise use. A more comprehensive 
understanding of the multi-dimensional appeal of these 
products will assist policymakers to target strategies to reduce 
the attractiveness to young smokers of these products.
Recent publications continued
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Individual differences in learning from probabilistic reward 
and punishment predicts smoking status
Rai LA, O'Halloran L, Jollans L, Vahey N, O'Brolchain C and 
Whelan R (2019) Addictive Behaviors, 88: 73–76.
https://www.drugsandalcohol.ie/29569/ 
The ability to update reward and punishment contingencies is 
a fundamental aspect of effective decision-making, requiring 
the ability to successfully adapt to the changing demands of 
one's environment. In the case of nicotine addiction, research 
has predominantly focused on reward- and punishment-
based learning processes among current smokers relative to 
non-smokers, whereas less is known about these processes in 
former smokers.
Current smokers and ex-smokers were less likely to learn 
from rewards, supporting the hypothesis that deficient reward 
processing is a feature of chronic addiction. In addition, current 
smokers were more sensitive to punishment than ex-smokers, 
contradicting some recent findings.
A multi-faceted intervention to reduce alcohol misuse and 
harm amongst sports people in Ireland: a controlled trial
O'Farrell A, Kingsland M, Kenny S, Eldin N, Wiggers J, Wolfenden 
L and Allwright S (2018) Drug and Alcohol Review, 37(1): 14–22.
https://www.drugsandalcohol.ie/29526/ 
The study aimed to test the effectiveness of an intervention 
to reduce alcohol misuse and related harms amongst amateur 
sports people in Ireland.
Intervention in community sports clubs may be effective in 
reducing the number of alcohol-related harms. Low levels of 
intervention participation and inadequate intervention dose are 
possible reasons for lack of a broader intervention effect.
Advances in management of neonatal abstinence syndrome: 
what’s the score?
Shanahan KM and O'Grady MJ (2018) Irish Medical Journal, 
111(7): 785.
https://www.drugsandalcohol.ie/29434/ 
Neonatal abstinence syndrome (NAS) is a constellation of 
symptoms and signs of withdrawal developing in infants 
following intrauterine exposure to opioids. In Ireland currently, 
this is typically methadone substitution for treatment of heroin 
addiction. In the United States, NAS has been declared an 
epidemic with a 5-fold increase in incidence between 2000 and 
2012 and a current prevalence as high as 2% of live births. In 
Ireland, data from the Hospital Inpatient Enquiry (HIPE) system 
indicates that between 2012 and 2016, 501 infants were treated 
for NAS; half of whom were in the three Dublin maternity 
hospitals. The most recent survey of practice within neonatal 
units in Ireland and the UK identified widespread variation 
in methods for assessment and treatment of NAS, reflecting 
the lack of quality evidence upon which current treatment 
regimens are based.
Cannabis oil in an Irish children’s critical care unit 
Fennessy P, Murphy L and Crowe S (2018) Irish Medical Journal, 
111(8): 807.     
Recent publications continued
RESPONSES
Allen Carr's Easyway to Stop Smoking – a randomised clinical 
trial
Keogan S, Li S and Clancy L (2018) Tobacco Control, Early 
online. https://www.drugsandalcohol.ie/29870/ 
To determine if Allen Carr's Easyway to Stop Smoking (AC) was 
superior to Quit.ie in a randomised clinical trial (RCT).
All AC quit rates were superior to Quit.ie, outcomes were 
comparable with established interventions.
A cost-effectiveness analysis of school-based suicide 
prevention programmes
Ahern S, Burke LA, McElroy B, Corcoran P, McMahon EM, Keeley 
H, et al. (2018) European Child & Adolescent Psychiatry, 27(10): 
1295–1304.
https://www.drugsandalcohol.ie/29779/ 
We aimed to conduct a full cost-effectiveness analysis 
(CEA) of the large pan-European school-based RCT, Saving 
and Empowering Young Lives in Europe (SEYLE). The health 
outcomes of interest were suicide attempt and severe suicidal 
ideation with suicide plans.
This CEA supports Youth Aware of Mental Health (YAM) as the 
most cost-effective of the SEYLE interventions in preventing 
both a suicide attempt and severe suicidal ideation. 
Dissociable psychosocial profiles of adolescent substance 
users
Fitzgerald A, Mac Giollabhui N, Dolphin L, Whelan R and Dooley 
B (2018) PLoS ONE, 13(8): e0202498.
https://www.drugsandalcohol.ie/29577/ 
The aim of the present study was to examine the role of the 
individual, family, school, peer, and social environment on 
alcohol (lifetime and risky), tobacco (risky only), and cannabis 
use (lifetime and riskiness).
This study indicates that the relationship between the 
environment and substance use is more complex than 
previously thought.
Feasibility of recruitment to a behavioural smoking cessation 
intervention combined with ongoing online support
Reynolds CME, Egan B, O'Malley EG, Kennedy RA, Sheehan SR 
and Turner MJ (2019) European Journal of Public Health, 29(1): 
170–72.
https://www.drugsandalcohol.ie/29559/ 
The aim of this randomized controlled trial was to determine 
whether a behavioural intervention in pregnancy supported 
by online information would improve smoking cessation rates. 
However, due to a number of challenges, recruitment to this 
trial was reluctantly halted. We aimed to recruit 220 maternal 
smokers within 2 years and after screening 1995 women, just 22 
enrolled over a 8-month period. Only three women accessed 
the online element of the intervention and, at follow up, no 
women reported quitting. We report our findings as they may 
inform the design and powering of future smoking cessation 
interventions in pregnancy.
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We present a case of a five-year-old female admitted 
postoperatively to the Paediatric Critical Care Unit with a 
history of refractory seizures for which her parents were 
administering cannabis oil.
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